TrojanDC – developing an off-the-shelf immunotherapy to turn cancer against itself
Asgard Therapeutics is developing the world’s first cancer immunotherapy based on cell reprogramming. We seek the next leap forward in immunotherapy employing Asgard’s proprietary technology to render cancer cells visible to the immune system in order to attack and eliminate them. This strategy disruptively combines cell reprogramming and immunotherapy, leading